Rubella control in France

In the pre-vaccination era, rubella was regarded as only a mild exanthematous acute viral infection of children. The devastating effects of the disease were first identified in the early 1940s by an Australian ophthalmologist, and further confirmed during the 1962-65 rubella pandemic in Europe and the United States. They result from the transmission of the virus by infected pregnant women to their fetus. The resulting congenital rubella syndrome(CRS) comprises a lengthy list of abnormalities. The most common ones are deafness, ocular and cardiac defects and mental retardation. The objective of rubella vaccination, to which France has subscribed, is the elimination of CRS

Author(s): Levy Bruhl D, Six C, Parent du Chatelet I

Publishing year: 2004

Pages: 15-6

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?